Indian actor Manmeet Singh announced significant weight loss and claimed health improvements, but lack of clinical evidence and conflicting profiles leave questions about the accuracy of his self-reported health journey. Days before an Indian Express health feature picked up the…
Researchers identify the metabolic enzyme FBP1 as a key obstacle in diabetic skin repair and develop a novel topical gel based on a natural compound derivative, showing promising results in mice and potentially paving the way for new treatments for…
Emerging evidence reveals that genetic makeup, age, and sex significantly influence individual responses to obesity drugs like Wegovy, raising questions about their universal efficacy and the need for personalised approaches. The surge in demand for Wegovy and similar obesity drugs…
Eli Lilly’s diabetes medication Mounjaro has received FDA approval for a new indication to reduce cardiovascular risk in high-risk adults with type 2 diabetes, marking a significant advancement in its clinical use and competitive positioning. Eli Lilly has won a…
Aurelio Rojas, a Málaga cardiologist popular on social media, recommends selecting fibre-rich, low-glycaemic fruits like kiwi, berries, and apples for evening consumption to improve sleep quality and support cardiovascular health, highlighting the impact of sugar intake on overnight metabolic processes.…
New research indicates that matching doses of semaglutide and tirzepatide yields comparable weight loss in type 2 diabetes, highlighting the potential for dose-based substitution amid supply and cost pressures. A new attempt to answer one of obesity and diabetes medicine’s…
A recent study challenges previous assumptions by showing that, when comparing doses directly, semaglutide’s effectiveness in weight reduction approaches that of tirzepatide, prompting a nuanced re-evaluation of their relative benefits. Average results have recently made tirzepatide look like the more…
Researchers have pinpointed a gene, ALDH3B2, that acts as a molecular brake on converting pancreatic duct cells into insulin-producing beta-like cells, opening new avenues for diabetes treatment beyond transplants and stem cells. A study now published in Science Translational Medicine…
The FDA’s approval of over-the-counter continuous glucose monitoring for children signals a major turning point in diabetes care, with market leaders Dexcom and Abbott expanding consumer access and boosting growth prospects in 2026. The blood glucose monitoring market is being…
The expanding market for continuous glucose monitors is heralding growth, but recent FDA actions against major players highlight trust and software risks that could shape the future of diabetes management technology. A bullish forecast for blood glucose monitoring systems is…
